Mendus AB (CHIX:IMMUS) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:IMMUS Mendus AB CHIX:IMMUS
31 GF Score
Price kr32.70
! 2 Warning Signs
View Full Analysis

What is Mendus AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CHIX:IMMUS vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, Mendus AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mendus AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mendus AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Mendus AB's Short Interest falls into.


CHIX:IMMUS
31GF Score
Mendus AB CHIX:IMMUS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mendus AB Business Description

Other Exchanges IMMU:Sweden1YG0:Germany
Address Vastra Tradgardsgatan 15, Stockholm, SWE, 11153
Mendus AB is a clinical-level biopharmaceutical company based on the company's allogeneic dendritic cell biology focused on the development of immunotherapies that address tumor recurrence and hard-to-treat established tumors. Its operations consist of research and development for pharmaceuticals. The company's Pipeline includes: Vididencel, and Ilixadencel.
31GF Score

Get the complete analysis for CHIX:IMMUS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr32.70
Price